Cell-specific conditional deletion of interleukin-1 (IL-1) ligands and its receptors: a new toolbox to study the role of IL-1 in health and disease
Open Access
- 29 May 2020
- journal article
- review article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 98 (7) , 923-930
Abstract
The pro-inflammatory cytokine interleukin-1 (IL-1) plays a key role in many physiological processes and during the inflammatory and immune response to most common diseases. IL-1 exists as two agonists, IL-1α and IL-1β that bind to the only signaling IL-1 type 1 receptor (IL-1R1), while a second decoy IL-1 type 2 receptor (IL-1R2) binds both forms of IL-1 without inducing cell signaling. The field of immunology and inflammation research has, over the past 35 years, unraveled many mechanisms of IL-1 actions, through in vitro manipulation of the IL-1 system or by using genetically engineered mouse models that lack either member of the IL-1 family in ubiquitous constitutive manner. However, the limitation of global mouse knockout technology has significantly hampered our understanding of the precise mechanisms of IL-1 actions in animal models of disease. Here we report and review the recent generation of new conditional mouse mutants in which exons ofIl1a,Il1b,Il1r1, andIl1r2genes flanked by loxP sites (fl/fl) can be deleted in cell-/tissue-specific constitutive or inducible manner by Cre recombinase expression. Hence, IL-1αfl/fl, IL-1βfl/fl, IL-1R1fl/fl, and IL-1R2fl/flmice constitute a new toolbox that will provide a step change in our understanding of the cell-specific role of IL-1 and its receptor in health and disease and the potential development of targeted IL-1 therapies.Keywords
Funding Information
- British Heart Foundation (PG/13/55/30365)
- Seventh Framework Programme (305564)
- Deutsche Forschungsgemeinschaft (CRC/TRR128, CRC1292)
This publication has 65 references indexed in Scilit:
- Interleukin-1R3 mediates interleukin-1–induced potassium current increase through fast activation of Akt kinaseProceedings of the National Academy of Sciences, 2012
- Oxygen–glucose deprivation and interleukin‐1α trigger the release of perlecan LG3 by cells of neurovascular unitJournal of Neurochemistry, 2011
- IL‐1‐dependent, IL‐1R1‐independent resistance to gastrointestinal nematodesEuropean Journal of Immunology, 2009
- Differential effects of interleukin-1 alpha and beta on interleukin-6 and chemokine synthesis in neuronesMolecular and Cellular Neuroscience, 2008
- Gene regulation by IL‐1β independent of IL‐1R1 in the mouse brainGlia, 2005
- Lack of Interleukin-1 Receptor Antagonist Modulates Plaque Composition in Apolipoprotein E–Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Keratin 14 Cre transgenic mice authenticate keratin 14 as an oocyte‐expressed proteinGenesis, 2004
- Interleukin-1 gene cluster polymorphisms in cerebral infarctionCytokine, 2003
- IL-1α, but not IL-1β, is required for contact-allergen-specific T cell activation during the sensitization phase in contact hypersensitivityInternational Immunology, 2001
- Production of Mice Deficient in Genes for Interleukin (IL)-1α, IL-1β, IL-1α/β, and IL-1 Receptor Antagonist Shows that IL-1β Is Crucial in Turpentine-induced Fever Development and Glucocorticoid SecretionJournal of Experimental Medicine, 1998